Genetic Aspects of Mycobacterium Tuberculosis Resistance to New Anti-Tuberculosis Drugs

Genetic Aspects of Mycobacterium Tuberculosis Resistance to New Anti-Tuberculosis Drugs

We analyzed 57 publications devoted to study of genetic mechanisms of formation of drug resistance of Mycobacterium tuberculosis to bedaquiline, delamanid, pretomanid, linezolid, and clofazimine. Identification of genetic factors of MTB drug resistance make the basis to search for new targets in dev...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Kukurika, E. I. Veselova, A. B. Peregudova
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2023-08-01
Series:	Туберкулез и болезни лёгких
Subjects:	drug resistance mycobacterium tuberculosis anti-tuberculosis drugs mutations
Online Access:	https://www.tibl-journal.com/jour/article/view/1738
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Drug resistance of <i>M. tuberculosis</i> (historical aspects, current level of knowledge)
by: I. A. Burmistrova, et al.
Published: (2020-02-01)

Editorial: Factors associated with drug resistance and virulence of Mycobacterium tuberculosis
by: Natalie Eva Nieuwenhuizen, et al.
Published: (2024-12-01)

Mutations associated with resistance to rifampicin and isoniazid identified in strains of the Mycobacterium tuberculosis complex by GenoType MTBDRplus in Panama, 2015–2021
by: Juan Domínguez González, et al.
Published: (2025-07-01)

Multiple Drug Resistance of Mycobacterium tuberculosis Isolated from New Cases of Respiratory Tract Tuberculosis
by: B. S. Kibrik, et al.
Published: (2020-05-01)

Pretomanid: Clinical Trials and Prospects to Be Used in Treatment Regimens for Multiple and Extensive Drug Resistant Tuberculosis
by: A. V. Kukurika
Published: (2021-07-01)

Characterization of drug susceptibility of Mycobacterium tuberculosis isolated from new cases of tuberculosis concurrent with HIV infection
by: G. V. Panov, et al.
Published: (2015-02-01)

Specific Profiles and Amplification of Resistance to Anti-tuberculosis Drugs in Tuberculosis Patients in the Republic of Karelia
by: Yu. M. Markelov, et al.
Published: (2022-10-01)

Drug-resistance patterns and associated mutations of Mycobacterium tuberculosis strains isolated from chronic kidney disease and diabetes mellitus patients in Ethiopia
by: Ayinalem Alemu, et al.
Published: (2025-06-01)

Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis
by: Shasank S. Swain, et al.
Published: (2020-01-01)

A cross-sectional study on the factors influencing drug resistance in clinical Mycobacterium tuberculosis in Hulunbuir, Inner Mongolia
by: Guo Huijun, et al.
Published: (2025-01-01)

Genetic polymorphism and phenotypic resistance of Mycobacterium tuberculosis to ofloxacin and moxifloxacin
by: D. V. Vаkhrushevа, et al.
Published: (2020-12-01)

Molecular epidemiology and drug resistance of Mycobacterium tuberculosis in a tertiary care hospital in northeastern Mexico
by: Amador Flores-Aréchiga, et al.
Published: (2023-12-01)

Frequency and Structure of Drug Resistance of M. tuberculosis in Pulmonary and Extrapulmonary Tuberculosis
by: P. K. Yablonskiy, et al.
Published: (2024-03-01)

Resistance Patterns of Mycobacterium tuberculosis to First-Line Anti-TB Drugs in Kaduna State, North-Western Nigeria
by: Aliyu, M. S., et al.
Published: (2020-06-01)

Heterogeneity of Mycobacterium tuberculosis drug resistance in respect of pharmacokinetics of anti-tuberculosis drugs as a basis for individual treatment regimen
by: S. A. Popov, et al.
Published: (2015-04-01)

Drug resistance profile of Mycobacterium tuberculosis complex isolated from pulmonary tuberculosis patients and their household contacts in central Ethiopia
by: Getachew Seid, et al.
Published: (2025-06-01)

Delamanid is a new anti-tuberculosis drug: use, limitations, and prospects
by: V. N. Zimina, et al.
Published: (2021-03-01)

Characterization and anti-tuberculosis effects of γδ T cells expanded and activated by Mycobacterium tuberculosis heat-resistant antigen
by: Fangzheng Guo, et al.
Published: (2025-12-01)

Cycloserine resistance among drug-resistant tuberculosis cases in Taiwan
by: Sheng-Han Wu, et al.
Published: (2025-07-01)

High prevalence of multidrug resistant tuberculosis in Djibouti: a retrospective study
by: Géraldine Boyer-Cazajous, et al.
Published: (2014-02-01)

Whole-genome sequencing reveals transmission pattern and drug resistance of Mycobacterium tuberculosis intra- or inter-hosts
by: Feng Ding, et al.
Published: (2025-01-01)

Novel mutation in efflux pump Rv1258c (Tap) gene in drug resistant clinical isolates of Mycobacterium tuberculosis in Iran
by: ShimaSadat Farzaneh, et al.
Published: (2024-02-01)

Drug resistance pattern, prevalence and risk factors for resistance to second line anti-tuberculosis drugs in Balochistan, Pakistan
by: Naila Samad, et al.
Published: (2024-09-01)

Prevalence of drug-resistant Mycobacterium tuberculosis and its associated factors among tuberculosis patients attending Dilla university referral hospital, Ethiopia
by: Melat Hatiya, et al.
Published: (2025-06-01)

An exploratory study on the application of nanopore sequencing for detecting Mycobacterium tuberculosis drug resistance in respiratory specimens
by: Niansa Wei, et al.
Published: (2025-06-01)

Identification of drug resistance-related virulence gene mutations in 667 clinical Mycobacterium tuberculosis isolates
by: Yu Zhang, et al.
Published: (2024-09-01)

Comparative Molecular Genetic Characteristics of <i>Mycobacterium tuberculosis</i> Cultures Isolated in the European Part of the Russian Federation in 1998–2003 and 2016–2021
by: S. N. Andreevskaya, et al.
Published: (2023-07-01)

Genomic decoding of drug-resistant tuberculosis transmission in Thailand over three decades
by: Naphatcha Thawong, et al.
Published: (2025-08-01)

Long-term Follow-up of Family Nidus of Tuberculosis Infection
by: A. V. Kukurika, et al.
Published: (2023-12-01)

Drug resistance in Mycobacterium tuberculosis: An evolutionary perspective and its adaptation to the lung microenvironment
by: Satyendra Shukla, et al.
Published: (2024-12-01)

EXPERIENCE OF USING BEDAQUILINE AND LINEZOLID IN THE INTEGRAL TREATMENT OF THE PULMONARY TUBERCULOSIS PATIENT WITH EXTENSIVE DRUG RESISTANCE OF M. TUBERCULOSIS
by: E. M. Zhukova, et al.
Published: (2016-10-01)

A comparative study using Xpert MTB/RIF and culture methods evaluates MassARRAY technology for rapid detection of Mycobacterium tuberculosis and drug resistance
by: Sufang Wu, et al.
Published: (2025-07-01)

Definition of drug resistance of Mycobacterium tuberculosis to antituberculosis drugs in patients with multidrugresistant tuberculosis and TB with extremely drug resistant depending on the case of the disease
by: Kryzhanovsky D.G., et al.
Published: (2014-11-01)

Investigation of delamanid, bedaquiline, and linezolid resistance rates and related gene mutations in multidrug-resistant Mycobacterium tuberculosis in regional tuberculosis reference laboratories of Iran
by: Nazanin Ahmad Khosravi, et al.
Published: (2025-08-01)

Analyzing Antibiotic Resistance in Clinical Mycobacterium tuberculosis Isolates using Microplate Alamar Blue Assay
by: Kamal Ahmadi1, 2 , 3, et al.
Published: (2023-12-01)

The New Definition and Epidemiology of Extensive Drug Resistant Tuberculosis in 2020
by: S. A. Sterlikov, et al.
Published: (2023-04-01)

Assessment of Haematological Parameters in Drug-Resistant TB
by: Abdulrazzaq Neamah Zghair
Published: (2023-03-01)

Multi-Drug Resistance of Mycobacterium Tuberculosis – the Problem of Modern Phthisiology
by: E. Yu. Zorkaltseva, et al.
Published: (2019-05-01)

Analysis of Isoniazid, Streptomycin and Ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco
by: Imane Chaoui, et al.
Published: (2009-05-01)

Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis
by: А. V. Kukurika
Published: (2022-10-01)